Effect of HPβCD on solubility and transdermal delivery of capsaicin through rat skin

被引:30
|
作者
Zi, Peng [1 ]
Yang, Xinghao [1 ]
Kuang, Huifen [1 ]
Yang, Yanshuang [1 ]
Yu, Lili [2 ]
机构
[1] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Lab Pharmaceu, Nanjing 210046, Peoples R China
[2] Nanjing Changao Pharmaceut Sci Technol Co Ltd, Nanjing 210022, Peoples R China
基金
中国国家自然科学基金;
关键词
capsaicin; hydroxypropyl-beta-cyclodextrin; hydrogel; in vitro percutaneous studies; histological analysis;
D O I
10.1016/j.ijpharm.2008.03.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We evaluated the ability of hydroxypropyl-p-cyclodextrin (HP beta CD) to influence the percutaneous absorption of capsaicin (CP) through isolated rat skin. Phase solubility analysis and phase distribution studies suggested the potential of HP beta CD as a solubilizer and permeation enhancer for CP. In vitro permeation studies showed the trend that, the penetration flux (J(s)) of CP increased with the increasing concentration of HP beta CD from 0 to 2.20% (w/v), and then decreased dramatically when the concentration of HP beta CD kept on increasing up to 15% (w/v). 2.20% (w/v) of HP beta CD provided both just adequate solubilization and preferred Js for the permeation of CP (0.075%, w/v). Similar change patterns of the permeation parameters were also observed in the hydrogels, but the J(s) of CP was reduced significantly along with the increasing concentration of Carbopol U21. Histological analysis showed an invasive action of HP beta CD on the stratum corneum (SC) of rat skin, which could only reduce the lag time (T-L) but could not increase the J(s) of CP. On the other hand, the complexation of HP beta CD with CP could attenuate this invasive action. It is inferred that excess of HP beta CD could not only disturb the percutaneous absorption of CP but also disrupt the structure of SC. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 50 条
  • [1] Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin
    Babu, RJ
    Pandit, JK
    DRUG DELIVERY, 2005, 12 (03) : 165 - 169
  • [2] Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin
    Babu, RJ
    Pandit, JK
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 271 (1-2) : 155 - 165
  • [3] Transdermal delivery of glucose through hairless rat skin in vitro: effect of multiple and simple emulsions
    Piemi, MPY
    de Luca, M
    Grossiord, JL
    Seiller, M
    Marty, JP
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 171 (02) : 207 - 215
  • [4] Transdermal delivery of Diclofenac sodium through rat skin from various formulations
    Özgüney I.S.
    Karasulu H.Y.
    Kantarci G.
    Sözer S.
    Güneri T.
    Ertan G.
    AAPS PharmSciTech, 7 (4)
  • [5] Transdermal delivery of diclofenac sodium through rat skin from various formulations
    Ozguney, Isik Sarigullu
    Karasulu, Hatice Yesim
    Kantarci, Gulten
    Sozer, Sumru
    Guneri, Tamer
    Ertan, Gokhan
    AAPS PHARMSCITECH, 2006, 7 (04):
  • [6] TRANSDERMAL DELIVERY OF BUPRENORPHINE THROUGH CADAVER SKIN
    ROY, SD
    ROOS, E
    SHARMA, K
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (02) : 126 - 130
  • [7] Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin
    Panchagnula, R
    Salve, PS
    Thomas, NS
    Jain, AK
    Ramarao, P
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 219 (1-2) : 95 - 105
  • [8] Effect of skin preparation on transdermal insulin delivery
    Cawley, PJ
    Zakzewski, C
    Wasilewski, J
    Ford, W
    PROCEEDINGS OF THE IEEE TWENTY-SECOND ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, 1996, : 50 - 51
  • [9] Transdermal delivery of timolol by electroporation through human skin
    Denet, AR
    Préat, V
    JOURNAL OF CONTROLLED RELEASE, 2003, 88 (02) : 253 - 262
  • [10] Synthesis and effect of two new penetration enhancers on the transdermal delivery of 5-fluorouracil through excised rat skin
    Hanif, RM
    Ping, QE
    Muo, FZ
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1998, 46 (09) : 1428 - 1431